Apotex alleged that selected US court docket judgments and FDA conclusions discriminated versus it, denied it least normal of remedy and expropriated its expenditure in pravastatin. Damages sought: US£eight million.In January 2011, just after protracted proceedings, the tribunal dismissed the manufacturer's assert on jurisdictional grounds and dis… Read More